2020-10-28
Cell Therapy CMO:
Ever Supreme offers the cell products (ADCV、DC-CIK、CIK、GDT and BMSC) needed by medical institution under the Regulations Governing Specific Cellular Therapeutic Technology of 2018 promogulated by Taiwan FDA.
Cells Products as CMO:
(1).Advantages of Ever Supreme Bio Technology in Marketing:
(2).Joint Medical Facilities in Taiwan
(3).RGSCTT Services
(4). Indications of Treatment by Ever Supreme under RGSCTT
(5). Clinical Data under RGSCTT (ADCV01)
■ Data shows that patients with reception of DC treatment survive longer.
■ A Stage IV colorectal cancer patient who had received DC therapy, whose tumor marker are drastically decreased and maintain stable.
(6). Clinical Data under RGSCTT(DC-CIK)
■ A Stage IV Hepatoma patient who had received DC-CIK therapy, whose tumor marker are maintained stable range, no deterioration.
■ A Stage IV Hepatoma patient who had received DC-CIK therapy, whose tumor marker are maintained stable range, no deterioration.
4.CPU sites
Look for
Product licensing, Joint-Venture, Strategic Alliance, Sales & Distribution
Booth No. M804